Publication | Open Access

Association of serum soluble Receptor for Advanced Glycation End-products with subclinical cerebrovascular disease: The Northern Manhattan Study (NOMAS)

Vascular DiseaseEndothelial DysfunctionPathologyAdvanced Glycation End-productsVascular BiologyNeurologyNorthern Manhattan StudyMicrovascular DysfunctionMedicineSerum Soluble ReceptorAtherosclerosis